{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:42:58Z","timestamp":1782276178712,"version":"3.54.5"},"reference-count":126,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"ANID-FONDECYT","award":["1212006"],"award-info":[{"award-number":["1212006"]}]},{"name":"ANID-FONDECYT","award":["3200646"],"award-info":[{"award-number":["3200646"]}]},{"name":"CONICYT-FONDEQUIP","award":["EQM150023"],"award-info":[{"award-number":["EQM150023"]}]},{"name":"ANID\u2013Millennium Science Initiative Program-IMII","award":["P09\/016-F"],"award-info":[{"award-number":["P09\/016-F"]}]},{"name":"ANID\u2013Millennium Science Initiative Program-IMII","award":["ICN09_016"],"award-info":[{"award-number":["ICN09_016"]}]},{"name":"SOCHED","award":["2019-09"],"award-info":[{"award-number":["2019-09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Primary aldosteronism (PA) is an endocrine related condition leading to arterial hypertension due to inappropriately high and unregulated aldosterone concentration. Recently, a broad spectrum of PA has been recognized, which brings new challenges associated with early identification of this condition that affect renal epithelial and extrarenal tissues. Reports have shown the potential role of extracellular vesicles (EVs) and EV cargo as novel and complementary biomarkers in diagnosis and prognosis of PA. In vivo and in vitro studies have identified specific EV surface antigens, EV-proteins, and EV microRNAs that can be useful to develop novel diagnostic algorithms to detect, confirm, or follow up the PA. Moreover, the study of EVs in the field of PA provides further insight in the pathophysiological mechanism of the PA disease.<\/jats:p>","DOI":"10.1210\/endocr\/bqab240","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:24:27Z","timestamp":1639704267000},"source":"Crossref","is-referenced-by-count":7,"title":["Primary Aldosteronism, Aldosterone, and Extracellular Vesicles"],"prefix":"10.1210","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-412X","authenticated-orcid":false,"given":"Cristian A","family":"Carvajal","sequence":"first","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute of Immunology and Immunotherapy (IMII-ICM), Santiago, Chile"},{"name":"Centro Traslacional de Endocrinolog\u00eda UC (CETREN-UC), Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-1468","authenticated-orcid":false,"given":"Alejandra","family":"Tapia-Castillo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute of Immunology and Immunotherapy (IMII-ICM), Santiago, Chile"},{"name":"Centro Traslacional de Endocrinolog\u00eda UC (CETREN-UC), Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute of Immunology and Immunotherapy (IMII-ICM), Santiago, Chile"},{"name":"Centro Traslacional de Endocrinolog\u00eda UC (CETREN-UC), Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-4434","authenticated-orcid":false,"given":"Carlos E","family":"Fardella","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute of Immunology and Immunotherapy (IMII-ICM), Santiago, Chile"},{"name":"Centro Traslacional de Endocrinolog\u00eda UC (CETREN-UC), Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"issue":"4","key":"2021121701151402900_CIT0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"2021121701151402900_CIT0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/5584_2016_26","article-title":"Endocrine hypertension: a practical approach","volume":"956","author":"Pappachan","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"12","key":"2021121701151402900_CIT0003","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021121701151402900_CIT0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2021121701151402900_CIT0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2021121701151402900_CIT0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrendo.2009.263","article-title":"Aldosterone and arterial hypertension","volume":"6","author":"Tomaschitz","year":"2010","journal-title":"Nat Rev Endocrinol."},{"issue":"8","key":"2021121701151402900_CIT0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrendo.2011.76","article-title":"A comprehensive review of the clinical aspects of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"2021121701151402900_CIT0008","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1515\/cclm-2017-0217","article-title":"Update in diagnosis and management of primary aldosteronism","volume":"56","author":"Dick","year":"2018","journal-title":"Clin Chem Lab Med."},{"issue":"4","key":"2021121701151402900_CIT0009","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension."},{"key":"2021121701151402900_CIT0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2015.00095","article-title":"Molecular and cellular mechanisms of aldosterone producing adenoma development","volume":"6","author":"Boulkroun","year":"2015","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"12","key":"2021121701151402900_CIT0011","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1055\/s-0043-122602","article-title":"Subtyping of patients with primary aldosteronism: an update","volume":"49","author":"Lenders","year":"2017","journal-title":"Horm Metab Res."},{"issue":"3","key":"2021121701151402900_CIT0012","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension."},{"key":"2021121701151402900_CIT0013","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2020.00121","article-title":"Long-term mortality for patients of primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2021121701151402900_CIT0014","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/HYPERTENSIONAHA.120.16909","article-title":"Time-dependent risk of atrial fibrillation in patients with primary aldosteronism after medical or surgical treatment initiation","volume":"77","author":"Kim","year":"2021","journal-title":"Hypertension."},{"issue":"2","key":"2021121701151402900_CIT0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension."},{"issue":"9","key":"2021121701151402900_CIT0016","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med."},{"issue":"8","key":"2021121701151402900_CIT0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11886-021-01538-8","article-title":"Primary aldosteronism: a continuum from normotension to hypertension","volume":"23","author":"Wannachalee","year":"2021","journal-title":"Curr Cardiol Rep."},{"issue":"5","key":"2021121701151402900_CIT0018","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021121701151402900_CIT0019","first-page":"800","article-title":"[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]","volume":"127","author":"Mosso","year":"1999","journal-title":"Rev Med Chil."},{"issue":"3","key":"2021121701151402900_CIT0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021121701151402900_CIT0021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08037051.2020.1723406","article-title":"Primary aldosteronism in a general population sample. The Czech Post-MONICA study","volume":"29","author":"Widimsk\u00fd","year":"2020","journal-title":"Blood Press."},{"key":"2021121701151402900_CIT0022","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2016.12.014","article-title":"Hypertension: the role of biochemistry in the diagnosis and management","volume":"465","author":"O\u2019Shea","year":"2017","journal-title":"Clin Chim Acta."},{"issue":"12","key":"2021121701151402900_CIT0023","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0043-119802","article-title":"Primary aldosteronism: the next five years","volume":"49","author":"Funder","year":"2017","journal-title":"Horm Metab Res."},{"issue":"5","key":"2021121701151402900_CIT0024","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021121701151402900_CIT0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem."},{"issue":"6","key":"2021121701151402900_CIT0026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The Expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev."},{"issue":"1","key":"2021121701151402900_CIT0027","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-14-0471","article-title":"Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals","volume":"224","author":"Young","year":"2015","journal-title":"J Endocrinol."},{"issue":"8","key":"2021121701151402900_CIT0028","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/01.ASN.0000132473.50966.14","article-title":"Mechanisms of hypertension: the expanding role of aldosterone","volume":"15","author":"Freel","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"2021121701151402900_CIT0029","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochim Biophys Acta."},{"issue":"1","key":"2021121701151402900_CIT0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","article-title":"Genomic and rapid effects of aldosterone: what we know and do not know thus far","volume":"22","author":"Hermidorff","year":"2017","journal-title":"Heart Fail Rev."},{"issue":"4","key":"2021121701151402900_CIT0031","doi-asserted-by":"crossref","first-page":"C1118","DOI":"10.1152\/ajpcell.2001.281.4.C1118","article-title":"Nongenomic regulation of ENaC by aldosterone","volume":"281","author":"Zhou","year":"2001","journal-title":"Am J Physiol Cell Physiol."},{"key":"2021121701151402900_CIT0032","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-pharmtox-010716-104651","article-title":"GPER (GPR30): a nongenomic receptor (GPCR) for steroid hormones with implications for cardiovascular disease and cancer","volume":"57","author":"Feldman","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"5","key":"2021121701151402900_CIT0033","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tem.2011.02.001","article-title":"Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?","volume":"22","author":"Gomez-Sanchez","year":"2011","journal-title":"Trends Endocrinol Metab."},{"issue":"2","key":"2021121701151402900_CIT0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension."},{"key":"2021121701151402900_CIT0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/bs.vh.2018.10.003","article-title":"Aldosterone, the mineralocorticoid receptor and mechanisms of cardiovascular disease","volume":"109","author":"Young","year":"2019","journal-title":"Vitam Horm."},{"issue":"1","key":"2021121701151402900_CIT0036","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol."},{"issue":"10","key":"2021121701151402900_CIT0037","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0b013e32833d0177","article-title":"Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients","volume":"28","author":"Stehr","year":"2010","journal-title":"J Hypertens."},{"issue":"4","key":"2021121701151402900_CIT0038","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/jpem.2010.052","article-title":"Primary aldosteronism and its impact on the generation of arterial hypertension, endothelial injury and oxidative stress","volume":"23","author":"Martinez-Aguayo","year":"2010","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2021121701151402900_CIT0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids."},{"issue":"3","key":"2021121701151402900_CIT0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"2","key":"2021121701151402900_CIT0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2007-0030","article-title":"A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function","volume":"29","author":"Connell","year":"2008","journal-title":"Endocr Rev."},{"issue":"3","key":"2021121701151402900_CIT0042","doi-asserted-by":"crossref","first-page":"e26; author reply e27","DOI":"10.1161\/HYPERTENSIONAHA.110.156273","article-title":"Hyperaldosteronism and left ventricular hypertrophy","volume":"56","author":"Sechi","year":"2010","journal-title":"Hypertension."},{"issue":"6","key":"2021121701151402900_CIT0043","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2174\/1566524011313060015","article-title":"Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage","volume":"13","author":"Mu\u00f1oz-Durango","year":"2013","journal-title":"Curr Mol Med."},{"key":"2021121701151402900_CIT0044","first-page":"1134","article-title":"Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation. Rev Med Chil","author":"Stehr","year":"2008"},{"issue":"3","key":"2021121701151402900_CIT0045","doi-asserted-by":"crossref","first-page":"F529","DOI":"10.1152\/ajprenal.00596.2010","article-title":"Aldosterone stimulates superoxide production in macula densa cells","volume":"301","author":"Zhu","year":"2011","journal-title":"Am J Physiol Renal Physiol."},{"issue":"9","key":"2021121701151402900_CIT0046","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF03346533","article-title":"Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha","volume":"32","author":"Carvajal","year":"2009","journal-title":"J Endocrinol Invest."},{"issue":"8","key":"2021121701151402900_CIT0047","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"2021121701151402900_CIT0048","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension."},{"issue":"2","key":"2021121701151402900_CIT0049","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol Cell Endocrinol."},{"issue":"1","key":"2021121701151402900_CIT0050","doi-asserted-by":"crossref","first-page":"e0145946","DOI":"10.1371\/journal.pone.0145946","article-title":"Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2016","journal-title":"PloS One."},{"issue":"9","key":"2021121701151402900_CIT0051","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest."},{"issue":"3","key":"2021121701151402900_CIT0052","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1074\/jbc.M116.739243","article-title":"Mineralocorticoid receptor deficiency in macrophages inhibits atherosclerosis by affecting foam cell formation and efferocytosis","volume":"292","author":"Shen","year":"2017","journal-title":"J Biol Chem."},{"issue":"8","key":"2021121701151402900_CIT0053","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/en.2016-1040","article-title":"Cardiac tissue injury and remodeling is dependent upon MR regulation of activation pathways in cardiac tissue macrophages","volume":"157","author":"Shen","year":"2016","journal-title":"Endocrinology."},{"issue":"10","key":"2021121701151402900_CIT0054","doi-asserted-by":"crossref","first-page":"e110950","DOI":"10.1371\/journal.pone.0110950","article-title":"Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice","volume":"9","author":"Li","year":"2014","journal-title":"PloS One."},{"issue":"3","key":"2021121701151402900_CIT0055","first-page":"197","article-title":"The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension","volume":"32","author":"Sch\u00fctten","year":"2017","journal-title":"Physiology (Bethesda)."},{"issue":"3","key":"2021121701151402900_CIT0056","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.110.155135","article-title":"Aldosterone, plasma Renin activity, and aldosterone\/renin ratio in a normotensive healthy pediatric population","volume":"56","author":"Martinez-Aguayo","year":"2010","journal-title":"Hypertension."},{"issue":"7","key":"2021121701151402900_CIT0057","first-page":"e13353","article-title":"The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges","volume":"73","author":"O\u2019Shea","year":"2019","journal-title":"Int J Clin Pract."},{"issue":"3","key":"2021121701151402900_CIT0058","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension."},{"issue":"25 suppl 2","key":"2021121701151402900_CIT0059","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation."},{"issue":"4","key":"2021121701151402900_CIT0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1081\/JDI-120039828","article-title":"Ankle brachial index independently predicts early kidney disease","volume":"26","author":"Kshirsagar","year":"2004","journal-title":"Ren Fail."},{"issue":"1","key":"2021121701151402900_CIT0061","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjcard.2015.03.043","article-title":"Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin c to predict early acute kidney injury and outcome in patients with acute heart failure","volume":"116","author":"Palazzuoli","year":"2015","journal-title":"Am J Cardiol."},{"issue":"1","key":"2021121701151402900_CIT0062","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00467-017-3816-z","article-title":"Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases","volume":"34","author":"St\u00e5hl","year":"2019","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"2021121701151402900_CIT0063","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"1","key":"2021121701151402900_CIT0064","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles."},{"issue":"5","key":"2021121701151402900_CIT0065","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/cvr\/cvz021","article-title":"Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury","volume":"115","author":"Neves","year":"2019","journal-title":"Cardiovasc Res."},{"issue":"11","key":"2021121701151402900_CIT0066","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","article-title":"Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure","volume":"16","author":"Amabile","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"2021121701151402900_CIT0067","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.119.12944","article-title":"Characterization and gene expression analysis of serum-derived extracellular vesicles in primary aldosteronism","volume":"74","author":"Burrello","year":"2019","journal-title":"Hypertension."},{"issue":"suppl 1","key":"2021121701151402900_CIT0068","first-page":"AP002","article-title":"Abstract P002: aldosterone promotes the release of miRNA-containing exosomes from endothelial cells, leading to uptake by smooth muscle cells","volume":"66","author":"Robertson","year":"2015","journal-title":"Hypertension"},{"issue":"10","key":"2021121701151402900_CIT0069","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0804037106","article-title":"Aldosterone activates endothelial exocytosis","volume":"106","author":"Jeong","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2021121701151402900_CIT0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/HYPERTENSIONAHA.119.13088","article-title":"Extracellular vesicles as biomarkers and biovectors in primary aldosteronism","volume":"74","author":"Neves","year":"2019","journal-title":"Hypertension."},{"issue":"3","key":"2021121701151402900_CIT0071","doi-asserted-by":"crossref","first-page":"e001842","DOI":"10.1161\/JAHA.112.001842","article-title":"Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence","volume":"1","author":"Burger","year":"2012","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"2021121701151402900_CIT0072","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.17136","article-title":"Characterization of circulating extracellular vesicle surface antigens in patients with primary aldosteronism","volume":"78","author":"Burrello","year":"2021","journal-title":"Hypertension."},{"key":"2021121701151402900_CIT0073","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fendo.2017.00230","article-title":"Urinary exosomes and their cargo: potential biomarkers for mineralocorticoid arterial hypertension?","volume":"8","author":"Barros","year":"2017","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2021121701151402900_CIT0074","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acc.2016.07.003","article-title":"Urine exosomes: an emerging trove of biomarkers","volume":"78","author":"Street","year":"2017","journal-title":"Adv Clin Chem."},{"issue":"4","key":"2021121701151402900_CIT0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ndt\/gfu362","article-title":"Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes","volume":"30","author":"Corbetta","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"2021121701151402900_CIT0076","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fcell.2020.00244","article-title":"Novel aspects of extracellular vesicles in the regulation of renal physiological and pathophysiological processes","volume":"8","author":"Rigalli","year":"2020","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"2021121701151402900_CIT0077","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.kint.2016.07.015","article-title":"Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury","volume":"90","author":"Vi\u00f1as","year":"2016","journal-title":"Kidney Int."},{"issue":"Pt 24","key":"2021121701151402900_CIT0078","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1113\/jphysiol.2011.220277","article-title":"Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells","volume":"589","author":"Street","year":"2011","journal-title":"J Physiol."},{"issue":"3","key":"2021121701151402900_CIT0079","doi-asserted-by":"crossref","first-page":"p25","DOI":"10.1159\/000274468","article-title":"Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients?","volume":"114","author":"Esteva-Font","year":"2010","journal-title":"Nephron Physiol."},{"issue":"3","key":"2021121701151402900_CIT0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.112.198135","article-title":"The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism","volume":"60","author":"van der Lubbe","year":"2012","journal-title":"Hypertension."},{"issue":"2","key":"2021121701151402900_CIT0081","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1681\/ASN.2014111137","article-title":"Activation of the endogenous renin-angiotensin-aldosterone system or aldosterone administration increases urinary exosomal sodium channel excretion","volume":"27","author":"Qi","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"2021121701151402900_CIT0082","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab032","article-title":"Proteomic profile of urinary extracellular vesicles identifies AGP1 as a potential biomarker of primary aldosteronism","author":"Barros","year":"2021;162(4):032","journal-title":"Endocrinology"},{"issue":"1","key":"2021121701151402900_CIT0083","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1359-6101(02)00054-0","article-title":"Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties","volume":"14","author":"Hochepied","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"issue":"29","key":"2021121701151402900_CIT0084","doi-asserted-by":"crossref","first-page":"22174","DOI":"10.1074\/jbc.M109.085464","article-title":"Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem."},{"issue":"3","key":"2021121701151402900_CIT0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/mend.11.3.9893","article-title":"Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum\/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein","volume":"11","author":"Maiyar","year":"1997","journal-title":"Mol Endocrinol."},{"issue":"12","key":"2021121701151402900_CIT0086","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/dna.1997.16.1467","article-title":"The glucocorticoid receptor regulates the binding of C\/EPBbeta on the alpha-1-acid glycoprotein promoter in vivo","volume":"16","author":"Savoldi","year":"1997","journal-title":"DNA Cell Biol."},{"key":"2021121701151402900_CIT0087","first-page":"139","article-title":"Molecular aspects of human alpha-1 acid glycoprotein\u2014structure and function","author":"Taguchi","year":"2013","journal-title":"Acute Phase Proteins"},{"issue":"4","key":"2021121701151402900_CIT0088","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/en.2006-1438","article-title":"Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?","volume":"148","author":"Fejes-T\u00f3th","year":"2007","journal-title":"Endocrinology."},{"issue":"4","key":"2021121701151402900_CIT0089","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcrc.2015.04.007","article-title":"\u03b1-1-Acid glycoprotein as a biomarker for the early diagnosis and monitoring the prognosis of sepsis","volume":"30","author":"Xiao","year":"2015","journal-title":"J Crit Care."},{"key":"2021121701151402900_CIT0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijcard.2016.11.134","article-title":"Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure","volume":"228","author":"Agra","year":"2017","journal-title":"Int J Cardiol."},{"issue":"2","key":"2021121701151402900_CIT0091","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/diabetes.52.2.442","article-title":"Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study","volume":"52","author":"Engstr\u00f6m","year":"2003","journal-title":"Diabetes."},{"issue":"2","key":"2021121701151402900_CIT0092","first-page":"331","article-title":"The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer","volume":"6","author":"Li","year":"2016","journal-title":"Am J Cancer Res."},{"issue":"2","key":"2021121701151402900_CIT0093","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension."},{"issue":"9","key":"2021121701151402900_CIT0094","doi-asserted-by":"crossref","first-page":"e73737","DOI":"10.1371\/journal.pone.0073737","article-title":"The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes","volume":"8","author":"Gravez","year":"2013","journal-title":"PloS One."},{"issue":"1","key":"2021121701151402900_CIT0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","article-title":"Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids","volume":"66","author":"Tarjus","year":"2015","journal-title":"Hypertension."},{"issue":"4","key":"2021121701151402900_CIT0096","first-page":"555","article-title":"Increased expression of neutrophil gelatinase-associated lipocalin receptor by interleukin-1\u03b2 in human mesangial cells via MAPK\/ERK activation","volume":"27","author":"Mao","year":"2011","journal-title":"Int J Mol Med."},{"issue":"1","key":"2021121701151402900_CIT0097","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.115.05479","article-title":"The central role of neutrophil gelatinase-associated lipocalin in cardiovascular fibrosis","volume":"66","author":"Leopold","year":"2015","journal-title":"Hypertension."},{"issue":"14","key":"2021121701151402900_CIT0098","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","article-title":"Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase","volume":"268","author":"Kjeldsen","year":"1993","journal-title":"J Biol Chem."},{"issue":"5","key":"2021121701151402900_CIT0099","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/00365519409088436","article-title":"Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils","volume":"54","author":"Xu","year":"1994","journal-title":"Scand J Clin Lab Invest."},{"issue":"4","key":"2021121701151402900_CIT0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ehf2.12183","article-title":"Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment","volume":"4","author":"Yang","year":"2017","journal-title":"ESC Heart Fail."},{"issue":"2","key":"2021121701151402900_CIT0101","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1681\/ASN.2008040406","article-title":"Large-scale proteomics and phosphoproteomics of urinary exosomes","volume":"20","author":"Gonzales","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"2021121701151402900_CIT0102","doi-asserted-by":"crossref","DOI":"10.1038\/s41440-021-00710-5","article-title":"Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism","author":"Ochiai-Homma","year":"2021;44:1557-1567","journal-title":"Hypertens Res"},{"issue":"1","key":"2021121701151402900_CIT0103","doi-asserted-by":"crossref","first-page":"17737","DOI":"10.1038\/s41598-017-18175-3","article-title":"Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep."},{"key":"2021121701151402900_CIT0104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA expression profiling in primary aldosteronism","volume":"10","author":"Decmann","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"2021121701151402900_CIT0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ki.2013.502","article-title":"Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine","volume":"86","author":"Cheng","year":"2014","journal-title":"Kidney Int."},{"key":"2021121701151402900_CIT0106","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1471-2164-14-319","article-title":"Characterization of human plasma-derived exosomal RNAs by deep sequencing","volume":"14","author":"Huang","year":"2013","journal-title":"BMC Genomics."},{"issue":"1","key":"2021121701151402900_CIT0107","doi-asserted-by":"crossref","first-page":"1725285","DOI":"10.1080\/20013078.2020.1725285","article-title":"Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells","volume":"9","author":"Mens\u00e0","year":"2020","journal-title":"J Extracell Vesicles."},{"issue":"5","key":"2021121701151402900_CIT0108","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/en.2007-1686","article-title":"Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells","volume":"149","author":"Romero","year":"2008","journal-title":"Endocrinology."},{"issue":"1","key":"2021121701151402900_CIT0109","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trsl.2014.06.007","article-title":"Epigenetics and arterial hypertension: the challenge of emerging evidence","volume":"165","author":"Friso","year":"2015","journal-title":"Transl Res."},{"issue":"3","key":"2021121701151402900_CIT0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1535370220974600","article-title":"Importance of extracellular vesicles in hypertension","volume":"246","author":"Liu","year":"2021","journal-title":"Exp Biol Med (Maywood)."},{"issue":"12","key":"2021121701151402900_CIT0111","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.clinbiochem.2013.05.052","article-title":"Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure","volume":"46","author":"Gildea","year":"2013","journal-title":"Clin Biochem."},{"issue":"22","key":"2021121701151402900_CIT0112","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/nar\/gnh186","article-title":"Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs","volume":"32","author":"Sun","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2021121701151402900_CIT0113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1101\/gr.6587008","article-title":"MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis","volume":"18","author":"Tian","year":"2008","journal-title":"Genome Res."},{"issue":"4","key":"2021121701151402900_CIT0114","doi-asserted-by":"crossref","first-page":"H1486","DOI":"10.1152\/ajpheart.00888.2020","article-title":"Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers","volume":"320","author":"Tan","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"2021121701151402900_CIT0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001101","article-title":"miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes","volume":"8","author":"Hu","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"2021121701151402900_CIT0116","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MNH.0000000000000192","article-title":"Urinary extracellular vesicles as markers to assess kidney sodium transport","volume":"25","author":"Salih","year":"2016","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"2021121701151402900_CIT0117","doi-asserted-by":"crossref","first-page":"40601","DOI":"10.1038\/srep40601","article-title":"Urinary exosomes contain MicroRNAs capable of paracrine modulation of tubular transporters in kidney","volume":"7","author":"Gracia","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"2021121701151402900_CIT0118","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12967-019-02143-8","article-title":"Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess","volume":"17","author":"Tapia-Castillo","year":"2019","journal-title":"J Transl Med."},{"issue":"4","key":"2021121701151402900_CIT0119","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension."},{"issue":"4","key":"2021121701151402900_CIT0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/HYPERTENSIONAHA.115.05659","article-title":"Let-7i: lethal weapon against angiotensin ii-induced cardiac injury","volume":"66","author":"Syed","year":"2015","journal-title":"Hypertension."},{"issue":"6","key":"2021121701151402900_CIT0121","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/en.2016-1707","article-title":"Role and regulation of MicroRNAs in aldosterone-mediated cardiac injury and dysfunction in male rats","volume":"158","author":"Ball","year":"2017","journal-title":"Endocrinology."},{"issue":"6","key":"2021121701151402900_CIT0122","doi-asserted-by":"crossref","first-page":"E1154","DOI":"10.1152\/ajpendo.00155.2018","article-title":"MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction","volume":"315","author":"Syed","year":"2018","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"2021121701151402900_CIT0123","doi-asserted-by":"crossref","article-title":"Let-7i-5p regulation of cell morphology and migration through distinct signaling pathways in normal and pathogenic fibroblasts from urethra","author":"Zhang","DOI":"10.1101\/330332"},{"issue":"11","key":"2021121701151402900_CIT0124","doi-asserted-by":"crossref","first-page":"23086","DOI":"10.3390\/ijms141123086","article-title":"Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells","volume":"14","author":"Bao","year":"2013","journal-title":"Int J Mol Sci."},{"key":"2021121701151402900_CIT0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","article-title":"Turning 21: Induction of miR-21 as a key switch in the inflammatory response","volume":"6","author":"Sheedy","year":"2015","journal-title":"Front Immunol."},{"issue":"3","key":"2021121701151402900_CIT0126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12265-010-9169-7","article-title":"MicroRNA-21 in cardiovascular disease","volume":"3","author":"Cheng","year":"2010","journal-title":"J Cardiovasc Transl Res."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/1\/bqab240\/41784467\/bqab240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/163\/1\/bqab240\/41784467\/bqab240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:26:15Z","timestamp":1639704375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqab240\/6433012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqab240","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,11,22]]},"article-number":"bqab240"}}